Satellos Bioscience
(NASDAQ) MSLE
Satellos Bioscience Financials at a Glance
Market Cap
$117.07M
Revenue (TTM)
$0.00
Net Income (TTM)
-$28.50M
EPS (TTM)
-$1.81
P/E Ratio
-3.10
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.51
Volume
46,601.984
Open
$5.73
Price
$6.51
Volume
46,601.984
Open
$5.73
Previous Close
$5.62
Daily Range
$5.72 - $6.50
52-Week Range
$4.56 - $13.39
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.51
Volume
46,601.984
Open
$5.73
Previous Close
$5.62
Daily Range
$5.72 - $6.50
52-Week Range
$4.56 - $13.39
Estimated Earnings Date
Aug 12, 2026
MSLE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Satellos Bioscience
Industry
Biotechnology
Sector
Health CareEmployees
18
CEO
Frank Gleeson, MBA
Website
www.satellos.comHeadquarters
Toronto, ON M5J 2J1, CA
MSLE Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-51.42%
Return on Capital
-95.23%
Return on Assets
-25.56%
Earnings Yield
-32.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$117.07M
Shares Outstanding
20.83M
Volume
46.60K
Avg. Volume
46.32K
Financials (TTM)
Gross Profit
-$5.00K
Operating Income
-$30.02M
EBITDA
-$30.02M
Operating Cash Flow
-$25.68M
Capital Expenditure
-$9.94K
Free Cash Flow
-$25.69M
Cash & ST Invst.
$70.14M
Total Debt
$0.00
Satellos Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$986.00
+1.1%
Gross Margin
0.00%
N/A
Market Cap
$117.07M
N/A
Market Cap/Employee
$6.50M
N/A
Employees
18
N/A
Net Income
-$9.77M
-59.1%
EBITDA
-$10.04M
-55.0%
Quarterly Fundamentals
Total Cash
$70.14M
+70.3%
Total Debt
$0.00
N/A
Accounts Receivable
$728.39K
+115.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-25.56%
N/A
Return on Invested Capital
-20.67%
N/A
Free Cash Flow
-$9.46M
-28.4%
Operating Cash Flow
-$9.45M
-28.3%